Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB1148 for recovery of gastrointestinal function after elective intestinal resection
CTR20190941Phase 2Completed
- Sponsor
- Leading BioSciences, Inc.
- Start
- Jun 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of LB1148 in postoperative ileus (POI), Gastrointestinal Dysmotility, intra-abdominal adhesions, sponsored by Leading BioSciences, Inc.. Started Jun 2019; status: completed.
02
Drugs
LB1148
03
Conditions
postoperative ileus (POI)Gastrointestinal Dysmotilityintra-abdominal adhesions
Beyond the preview
Go deeper on CTR20190941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190941.